[kragen]

Also, the person you were shouting at and saying "Hint" to probably knows about 100 times more than you do about the economics of drug companies.

[erosenbe0]

Sure, if we are talking about on-patent drugs I don't know that much. But if we are talking about off-patent generics there isn't a lot to know. We in the United States have a variety of financial, temporal, regulatory, and competitive barriers that bloat prices, sometimes by a factor of 100, over consumer market price in somewhere like India, or even Mexico.